CR11620A - Derivados de Imadazo-[1,2,b]-Piridazina para el Tratamiento de Enfermedad Mediada por Cinosa de Tirosina C-Met - Google Patents
Derivados de Imadazo-[1,2,b]-Piridazina para el Tratamiento de Enfermedad Mediada por Cinosa de Tirosina C-MetInfo
- Publication number
- CR11620A CR11620A CR11620A CR11620A CR11620A CR 11620 A CR11620 A CR 11620A CR 11620 A CR11620 A CR 11620A CR 11620 A CR11620 A CR 11620A CR 11620 A CR11620 A CR 11620A
- Authority
- CR
- Costa Rica
- Prior art keywords
- tyrosine
- piridazine
- imadazo
- derivatives
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La invencion se refiere a los compuestos de la formula (I) y sales de los mismos, en donde los sustituyentes son como se definen en la memoria descriptiva, a la aplicacion de un compuesto de la formula (I).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08152068 | 2008-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11620A true CR11620A (es) | 2010-10-08 |
Family
ID=39672115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11620A CR11620A (es) | 2008-02-28 | 2010-08-06 | Derivados de Imadazo-[1,2,b]-Piridazina para el Tratamiento de Enfermedad Mediada por Cinosa de Tirosina C-Met |
Country Status (25)
Country | Link |
---|---|
US (1) | US8822468B2 (es) |
EP (1) | EP2265614A1 (es) |
JP (1) | JP5576802B2 (es) |
KR (1) | KR20100128305A (es) |
CN (1) | CN102015716B (es) |
AR (1) | AR070487A1 (es) |
AU (1) | AU2009218459A1 (es) |
BR (1) | BRPI0908504A2 (es) |
CA (1) | CA2717034A1 (es) |
CL (1) | CL2009000443A1 (es) |
CO (1) | CO6300957A2 (es) |
CR (1) | CR11620A (es) |
DO (1) | DOP2010000263A (es) |
EA (1) | EA201001365A1 (es) |
EC (1) | ECSP10010427A (es) |
IL (1) | IL207434A0 (es) |
MA (1) | MA32167B1 (es) |
MX (1) | MX2010009414A (es) |
NI (1) | NI201000145A (es) |
PE (1) | PE20091468A1 (es) |
SM (1) | SMAP201000112A (es) |
TW (1) | TW200940545A (es) |
UY (1) | UY31676A1 (es) |
WO (1) | WO2009106577A1 (es) |
ZA (1) | ZA201005602B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY32049A (es) | 2008-08-14 | 2010-03-26 | Takeda Pharmaceutical | Inhibidores de cmet |
US20110053968A1 (en) | 2009-06-09 | 2011-03-03 | Auspex Pharmaceuticals, Inc. | Aminopyrimidine inhibitors of tyrosine kinase |
US8389526B2 (en) * | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
AU2010283806A1 (en) | 2009-08-12 | 2012-03-01 | Novartis Ag | Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
AU2010284972A1 (en) | 2009-08-20 | 2012-03-08 | Novartis Ag | Heterocyclic oxime compounds |
DK3511330T3 (da) * | 2009-12-31 | 2020-12-21 | Hutchison Medipharma Ltd | Syntetisk mellemprodukt, der er anvendeligt til fremstilling af triazolopyridin-c-met-inhibitorer |
US20110195066A1 (en) * | 2010-02-05 | 2011-08-11 | Auspex Pharmaceuticals, Inc. | Quinoline inhibitors of tyrosine kinase |
WO2012003338A1 (en) * | 2010-07-01 | 2012-01-05 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
AR085183A1 (es) | 2010-07-30 | 2013-09-18 | Lilly Co Eli | Compuesto 6-(1-metil-1h-pirazol-4-il)-3-(2-metil-2h-indazol-5-iltio)-[1,2,4]triazol[4,3-b]piridazina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar cancer |
UY33597A (es) * | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
EP2723748B1 (en) * | 2011-06-22 | 2016-10-12 | Bayer Intellectual Property GmbH | Heterocyclyl aminoimidazopyridazines |
BR112014006223A8 (pt) | 2011-09-15 | 2018-01-09 | Novartis Ag | 3-(quinolin-6-iltio)-[1,2,4-triazol[4,3-a] piradinas 6-substituídas, seus usos, composições farmacêuticas, e combinação |
CN103958509B (zh) * | 2011-09-15 | 2015-12-23 | 诺华股份有限公司 | 作为酪氨酸激酶抑制剂的6-取代的3-(喹啉-6-基硫代)-[1,2,4]三唑并[4,3-a]吡啶化合物 |
CN103122000B (zh) * | 2012-09-03 | 2013-12-25 | 中美冠科生物技术(太仓)有限公司 | 用作抗肿瘤药物的高选择性的c-Met激酶抑制剂 |
ME03042B (me) | 2012-11-19 | 2018-10-20 | Novartis Ag | Jedinjenja i kompozicije za tretman parazitskih oboljenja |
CA2901427A1 (en) | 2013-03-07 | 2014-09-12 | Califia Bio, Inc. | Mixed lineage kinase inhibitors and method of treatments |
AR097543A1 (es) * | 2013-09-06 | 2016-03-23 | Lexicon Pharmaceuticals Inc | COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO |
CN105326793A (zh) * | 2014-08-06 | 2016-02-17 | 中美冠科生物技术(太仓)有限公司 | 一种包含c-Met激酶抑制剂的固体分散体及其制备方法和用途 |
EA029789B1 (ru) * | 2014-12-19 | 2018-05-31 | Янссен Фармацевтика Нв | ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ |
DK3233839T3 (da) * | 2014-12-19 | 2019-12-09 | Janssen Pharmaceutica Nv | Heterocyclylkoblede imidazopyridazinderivater som pi3k-beta-inhibitorer |
AU2017326116B2 (en) * | 2016-09-16 | 2020-10-22 | Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) | TRAF 6 inhibitors |
WO2018138050A1 (de) | 2017-01-26 | 2018-08-02 | Bayer Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
WO2018237349A1 (en) * | 2017-06-23 | 2018-12-27 | University Of Washington | TYPE 1 METHIONYL-ARNT SYNTHASEASE INHIBITORS AND METHODS OF USE |
CN115087657A (zh) * | 2019-12-18 | 2022-09-20 | 加利福尼亚大学董事会 | Lin28抑制剂和其使用方法 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3489755A (en) | 1966-08-03 | 1970-01-13 | Pfizer & Co C | Imidazo (1,2-b) pyridazines |
GB8719368D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Heterocyclic compounds |
FR2619818B1 (fr) | 1987-09-01 | 1990-01-12 | Sanofi Sa | Imidazo (1,2-b) pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant |
CA2057089A1 (en) | 1990-12-07 | 1992-06-08 | Eric E. Allen | Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists |
DK1277754T3 (da) | 2000-04-27 | 2005-11-14 | Astellas Pharma Inc | Imidazopyridinderivater |
TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
WO2004058749A1 (en) | 2002-12-18 | 2004-07-15 | Vertex Pharmaceuticals Incorporated | Benzisoxazole derivatives useful as inhibitors of protein kinases |
CN1816528A (zh) | 2003-06-30 | 2006-08-09 | 麦克公司 | 作为雄激素受体调节剂的17-乙酰氨基-4-氮杂甾类衍生物 |
US7037909B2 (en) | 2003-07-02 | 2006-05-02 | Sugen, Inc. | Tetracyclic compounds as c-Met inhibitors |
US7122548B2 (en) | 2003-07-02 | 2006-10-17 | Sugen, Inc. | Triazolotriazine compounds and uses thereof |
CA2542536A1 (en) | 2003-10-21 | 2005-05-12 | Merck & Co., Inc. | Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain |
AU2004293018B2 (en) | 2003-11-19 | 2010-02-18 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
WO2005073224A2 (en) | 2004-01-23 | 2005-08-11 | Amgen Inc | Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer |
EP1713784A1 (en) | 2004-02-12 | 2006-10-25 | Neurogen Corporation | Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands |
US7456289B2 (en) | 2004-12-31 | 2008-11-25 | National Health Research Institutes | Anti-tumor compounds |
KR100973609B1 (ko) | 2005-03-23 | 2010-08-03 | 에프. 호프만-라 로슈 아게 | mGluR2 길항제로서 아세틸렌일-피라졸로-피리미딘유도체 |
EP1881986A2 (en) | 2005-05-12 | 2008-01-30 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
US20100216798A1 (en) * | 2005-07-29 | 2010-08-26 | Astellas Pharma Inc | Fused heterocycles as lck inhibitors |
US20070078136A1 (en) | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
US7348325B2 (en) | 2005-11-30 | 2008-03-25 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
CA2630884A1 (en) | 2005-11-30 | 2007-06-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-met and uses thereof |
RS55630B1 (sr) | 2005-12-21 | 2017-06-30 | Janssen Pharmaceutica Nv | Triazolopiridazini kao modulatori tirozin kinaze |
NL2000613C2 (nl) | 2006-05-11 | 2007-11-20 | Pfizer Prod Inc | Triazoolpyrazinederivaten. |
EP2032578A2 (en) | 2006-05-30 | 2009-03-11 | Pfizer Products Incorporated | Triazolopyridazine derivatives |
US8198448B2 (en) * | 2006-07-14 | 2012-06-12 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
PE20080403A1 (es) * | 2006-07-14 | 2008-04-25 | Amgen Inc | Derivados heterociclicos fusionados y metodos de uso |
US8217177B2 (en) | 2006-07-14 | 2012-07-10 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
CA2659971A1 (en) | 2006-08-04 | 2008-02-07 | Takeda Pharmaceutical Company Limited | Fused heterocyclic derivative and use thereof |
US7683060B2 (en) | 2006-08-07 | 2010-03-23 | Incyte Corporation | Triazolotriazines as kinase inhibitors |
WO2008030744A2 (en) | 2006-09-05 | 2008-03-13 | Board Of Regents, The University Of Texas System | Inhibitors of c-met and uses thereof |
CN101594909A (zh) | 2006-09-07 | 2009-12-02 | 比奥根艾迪克Ma公司 | 用于治疗炎性病症、细胞增殖性失调、免疫失调的irak调节剂 |
AU2007309237B2 (en) | 2006-10-23 | 2012-03-22 | Sgx Pharmaceuticals, Inc. | Triazolo-pyridazine protein kinase modulators |
LT3034075T (lt) | 2006-11-22 | 2018-11-26 | Incyte Holdings Corporation | Imidazotriazinai ir imidazopirimidinai kaip kinazės inhibitoriai |
AR064420A1 (es) | 2006-12-21 | 2009-04-01 | Alcon Mfg Ltd | Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop). |
US8125627B2 (en) | 2007-04-27 | 2012-02-28 | Alakai Defense Systems, Inc. | Laser spectroscopy system |
WO2008155378A1 (en) | 2007-06-21 | 2008-12-24 | Janssen Pharmaceutica Nv | Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline |
WO2009060197A1 (en) * | 2007-11-08 | 2009-05-14 | Centro Nacional De Investigaciones Oncologicas (Cnio) | Imidazopyridazines for use as protein kinase inhibitors |
WO2009088955A2 (en) | 2007-12-31 | 2009-07-16 | Energenox, Inc. | Boundary layer effect turbine |
JP2009227599A (ja) | 2008-03-21 | 2009-10-08 | Daiichi Sankyo Co Ltd | イミダゾピリダジン誘導体 |
-
2009
- 2009-02-26 WO PCT/EP2009/052302 patent/WO2009106577A1/en active Application Filing
- 2009-02-26 PE PE2009000287A patent/PE20091468A1/es not_active Application Discontinuation
- 2009-02-26 EA EA201001365A patent/EA201001365A1/ru unknown
- 2009-02-26 AR ARP090100659A patent/AR070487A1/es unknown
- 2009-02-26 BR BRPI0908504-1A patent/BRPI0908504A2/pt not_active IP Right Cessation
- 2009-02-26 KR KR1020107021426A patent/KR20100128305A/ko not_active Application Discontinuation
- 2009-02-26 UY UY031676A patent/UY31676A1/es not_active Application Discontinuation
- 2009-02-26 CA CA2717034A patent/CA2717034A1/en not_active Abandoned
- 2009-02-26 MX MX2010009414A patent/MX2010009414A/es not_active Application Discontinuation
- 2009-02-26 CN CN200980114928.XA patent/CN102015716B/zh not_active Expired - Fee Related
- 2009-02-26 AU AU2009218459A patent/AU2009218459A1/en not_active Abandoned
- 2009-02-26 EP EP09714429A patent/EP2265614A1/en not_active Withdrawn
- 2009-02-26 JP JP2010548110A patent/JP5576802B2/ja not_active Expired - Fee Related
- 2009-02-27 TW TW098106564A patent/TW200940545A/zh unknown
- 2009-02-27 CL CL2009000443A patent/CL2009000443A1/es unknown
- 2009-03-02 US US12/396,137 patent/US8822468B2/en not_active Expired - Fee Related
-
2010
- 2010-08-05 ZA ZA2010/05602A patent/ZA201005602B/en unknown
- 2010-08-05 IL IL207434A patent/IL207434A0/en unknown
- 2010-08-06 CR CR11620A patent/CR11620A/es not_active Application Discontinuation
- 2010-08-27 EC EC2010010427A patent/ECSP10010427A/es unknown
- 2010-08-27 CO CO10106017A patent/CO6300957A2/es not_active Application Discontinuation
- 2010-08-27 DO DO2010000263A patent/DOP2010000263A/es unknown
- 2010-08-27 NI NI201000145A patent/NI201000145A/es unknown
- 2010-09-24 MA MA33198A patent/MA32167B1/fr unknown
- 2010-09-28 SM SM201000112T patent/SMAP201000112A/it unknown
Also Published As
Publication number | Publication date |
---|---|
AR070487A1 (es) | 2010-04-07 |
KR20100128305A (ko) | 2010-12-07 |
UY31676A1 (es) | 2009-09-30 |
CA2717034A1 (en) | 2009-09-03 |
EA201001365A1 (ru) | 2011-04-29 |
TW200940545A (en) | 2009-10-01 |
MA32167B1 (fr) | 2011-03-01 |
DOP2010000263A (es) | 2010-09-30 |
IL207434A0 (en) | 2010-12-30 |
PE20091468A1 (es) | 2009-10-22 |
EP2265614A1 (en) | 2010-12-29 |
ZA201005602B (en) | 2011-04-28 |
US20090264406A1 (en) | 2009-10-22 |
SMAP201000112A (it) | 2010-11-12 |
US8822468B2 (en) | 2014-09-02 |
JP5576802B2 (ja) | 2014-08-20 |
CN102015716B (zh) | 2014-09-17 |
MX2010009414A (es) | 2010-09-24 |
AU2009218459A1 (en) | 2009-09-03 |
CL2009000443A1 (es) | 2010-09-10 |
BRPI0908504A2 (pt) | 2015-08-11 |
WO2009106577A1 (en) | 2009-09-03 |
CO6300957A2 (es) | 2011-07-21 |
NI201000145A (es) | 2011-03-02 |
JP2011513279A (ja) | 2011-04-28 |
CN102015716A (zh) | 2011-04-13 |
ECSP10010427A (es) | 2010-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11620A (es) | Derivados de Imadazo-[1,2,b]-Piridazina para el Tratamiento de Enfermedad Mediada por Cinosa de Tirosina C-Met | |
UY36907A (es) | Nuevas carboxamidas de acción microbiocida | |
CU20110052A7 (es) | Compuestos orgánicos | |
CR11145A (es) | Pirazol amidas de acidos carboxilico utiles como microbicidas | |
ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
CO6321276A2 (es) | Derivados de tiazol usados como inhibidores de pi3- cinasa | |
UY32848A (es) | Compuestos heterocíclicos de oxima | |
ECSP109945A (es) | Nuevos herbicidas | |
CR10233A (es) | Piridin-4-ilmetilamidas | |
CR11241A (es) | Compuestos de pirazol y su uso como inhibidores de raf | |
ECSP10010014A (es) | Derivados de 2-alquiltio-2-quinoliniloxi-acetamida como fungicidas | |
CU20110078A7 (es) | Compuestos de carbazol | |
UY31166A1 (es) | Nuevos indazoles sustituidos, su preparación y su utilización en terapeutica | |
ECSP099818A (es) | Procesos para la preparacion de pirazoles | |
UY30600A1 (es) | Compuestos novedosos | |
ECSP109942A (es) | Nuevos herbicidas | |
CO6361989A2 (es) | Proceso para la preparacion de derivados de l-alanina protegidos | |
PE20151025A1 (es) | Nuevos derivados de piridina | |
ECSP11011244A (es) | Nuevos herbicidas. | |
ECSP11011218A (es) | Herbicidas derivados de ciclopentanodiona. | |
UY29478A1 (es) | Compuestos heteroaromaticos acilaminobiciclicos y sus usos | |
ECSP11011133A (es) | Nuevos herbicidas. | |
UY32667A (es) | Nuevos derivados de furano espiroheterocíclico y tiofuranodiona | |
UY32748A (es) | 2-carboxamida-cicloamino-ureas | |
CR10637A (es) | Fungicidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |